Michelle Linterman received her PhD in Immunology from the Australian National University in Canberra, where she investigated a novel mechanism of immunological tolerance; a phenomenon by which the immune system fails to respond to an antigen. She is currently Group Leader at the Babraham Institute and her principle research focus is on how the immune system responds to vaccination.

Babraham Institute profile